These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32415030)

  • 41. Pain in atypical parkinsonism, vascular parkinsonism, and Parkinson's disease.
    Sung YH; Kang SY
    Neurol Sci; 2022 Aug; 43(8):4797-4802. PubMed ID: 35347528
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients.
    Sankhla CS; Patil KB; Sawant N; Gupta S
    Neurol India; 2016; 64(2):239-45. PubMed ID: 26954800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?
    Williams DR; Lees AJ
    Mov Disord; 2010 Feb; 25(3):357-62. PubMed ID: 20108379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson's syndrome, and idiopathic Parkinson's disease.
    Pinkhardt EH; Jürgens R; Becker W; Valdarno F; Ludolph AC; Kassubek J
    J Neurol; 2008 Dec; 255(12):1916-25. PubMed ID: 19224319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study.
    Linder J; Stenlund H; Forsgren L
    Mov Disord; 2010 Feb; 25(3):341-8. PubMed ID: 20108376
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Olfaction in Neuropathologically Defined Progressive Supranuclear Palsy.
    Shill HA; Zhang N; Driver-Dunckley E; Mehta S; Adler CH; Beach TG
    Mov Disord; 2021 Jul; 36(7):1700-1704. PubMed ID: 33755262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group.
    Caparros-Lefebvre D; Elbaz A
    Lancet; 1999 Jul; 354(9175):281-6. PubMed ID: 10440304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autonomic dysfunction in patients with progressive supranuclear palsy.
    Schmidt C; Herting B; Prieur S; Junghanns S; Schweitzer K; Reichmann H; Berg D; Ziemssen T
    Mov Disord; 2008 Oct; 23(14):2083-9. PubMed ID: 18792126
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A differential diagnosis of Parkinsonism.
    Weiner WJ
    Rev Neurol Dis; 2005; 2(3):124-31. PubMed ID: 16400311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Presence of Skin α-Synuclein Deposits Discriminates Parkinson's Disease from Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Giannoccaro MP; Avoni P; Rizzo G; Incensi A; Infante R; Donadio V; Liguori R
    J Parkinsons Dis; 2022; 12(2):585-591. PubMed ID: 34864689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Differential Diagnosis and Treatment of Atypical Parkinsonism.
    Levin J; Kurz A; Arzberger T; Giese A; Höglinger GU
    Dtsch Arztebl Int; 2016 Feb; 113(5):61-9. PubMed ID: 26900156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medio-lateral balance impairment differentiates between Parkinson's disease and atypical parkinsonism.
    Nonnekes J; Aerts MB; Abdo WF; Bloem BR
    J Parkinsons Dis; 2014; 4(4):567-9. PubMed ID: 25125484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Connected speech in progressive supranuclear palsy: a possible role in differential diagnosis.
    Del Prete E; Tommasini L; Mazzucchi S; Frosini D; Palermo G; Morganti R; Pagni C; Tognoni G; Bonuccelli U; Ceravolo R
    Neurol Sci; 2021 Apr; 42(4):1483-1490. PubMed ID: 32851538
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome.
    Hesse S; Oehlwein C; Barthel H; Schwarz J; Polster D; Wagner A; Sabri O
    J Neural Transm (Vienna); 2006 Sep; 113(9):1177-90. PubMed ID: 16463120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Real-life benefits of intrajejunal levodopa infusion therapy in four patients with the parkinsonian variant of progressive supranuclear palsy: A 1-year follow-up data report.
    Metta V; Chaudhuri KR; Leta V; Mridula KR; Koduri C; Deepak S; Kalpala R; Reddy N; Chung-Faye G; Borgohain R
    Brain Behav; 2022 Sep; 12(9):e2547. PubMed ID: 35943202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. REM sleep behavior disorder in patients with guadeloupean parkinsonism, a tauopathy.
    De Cock VC; Lannuzel A; Verhaeghe S; Roze E; Ruberg M; Derenne JP; Willer JC; Vidailhet M; Arnulf I
    Sleep; 2007 Aug; 30(8):1026-32. PubMed ID: 17702273
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease.
    Spiegel J; Hellwig D; Samnick S; Jost W; Möllers MO; Fassbender K; Kirsch CM; Dillmann U
    J Neural Transm (Vienna); 2007 Mar; 114(3):331-5. PubMed ID: 16715205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PSP-Richardson syndrome mimics: An overview and pragmatic approach.
    Necpál J; Borsek M; Jeleňová B
    Rev Neurol (Paris); 2024; 180(1-2):12-23. PubMed ID: 37543508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Levodopa responsiveness in disorders with parkinsonism: a review of the literature.
    Constantinescu R; Richard I; Kurlan R
    Mov Disord; 2007 Nov; 22(15):2141-8; quiz 2295. PubMed ID: 17534959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.